Skip to main content
SpringerLink
Log in

Costs in warfarin-sensitive versus warfarin-insensitive patients

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2017 US dollars

Reference

  • Swanson KM, et al. Comparing outcomes and costs among warfarin-sensitive patients versus warfarin-insensitive patients using The Right Drug, Right Dose, Right Time: Using genomic data to individualize treatment (RIGHT) 10K warfarin cohort. PLOS One : 19 May 2020. Available from: URL: https://doi.org/10.1371/journal.pone.0233316

    Article  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Costs in warfarin-sensitive versus warfarin-insensitive patients. PharmacoEcon Outcomes News 854, 15 (2020). https://doi.org/10.1007/s40274-020-6845-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6845-y

Search

Navigation